PMCB
PharmaCyte Biotech Inc

5,588
Loading...
Loading...
News
all
press releases
News Placeholder
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (PharmaCyte or the Company), today announced a $7 million investment in MyMD Pharmaceuticals, Inc. (Nasdaq:MYMD) (MyMD) a clinical stage biopharmaceutical...
Business Wire·1y ago
News Placeholder
PharmaCyte Biotech (NASDAQ:PMCB) Trading Down 1.6%
PharmaCyte Biotech, Inc. (NASDAQ:PMCB Get Free Report)s stock price dropped 1.6% during mid-day trading on Tuesday . The stock traded as low as $2.34 and last traded at $2.44...
Zolmax·1y ago
News Placeholder
PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Sees Significant Drop in Short Interest
PharmaCyte Biotech, Inc. (NASDAQ:PMCB Get Free Report) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 26,500 shares, a...
Ticker Report·2y ago

Latest PMCB News

View

Advertisement. Remove ads.

Advertisement. Remove ads.